MedTrace Logo

Cytal® Wound Matrix and MicroMatrix® Wound Study

NCT03632954 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2021-05-11

Study results available
· View outcomes & findings →

Summary

This is an observational study to assess the safety and efficacy of MicroMatrix® alone or in combination with Cytal® Wound Matrix on primary measures of wound healing.

Conditions

  • Wounds

Interventions

DEVICE

ACell Arm

Cytal® Wound Matrix and/or MicroMatrix®

Sponsors & Collaborators

  • Winthrop University Hospital

    collaborator OTHER

  • Integra LifeSciences Corporation

    lead INDUSTRY

Principal Investigators

  • Allison Matthews · Integra LifeSciences Corporation

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-11
Primary Completion
2020-01-27
Completion
2020-01-27
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03632954 on ClinicalTrials.gov